Rapid AI logo

iSchemaView, Inc.

Biotechnology

Rapid AI Stock

Rapid AI is a leader in advanced imaging and workflow solutions for neurovascular, cardiac, and vascular diseases, utilizing artificial intelligence to improve the diagnosis and treatment of these conditions. Their technology, developed from research at the Stanford Stroke Center, provides critical insights for healthcare professionals.

Founded: 2011

Rapid AI Website

Management Team

Karim Karti Chief Executive Officer
David Stoffel Chief Business Officer
Dr. Greg Albers Chairman, Co-Founder and Scientific Lead
Dr. Roland Bammer Co-Founder and Technical Advisor

Funding Information